Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MTS Plazomicin 0.016-256 µg/mL

K-Number: K181708 · 2018-07-31

Decision Date2018-07-31
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MTS Plazomicin 0.016-256 µg/mL is a medical device manufactured by Liofilchem s.r.l.. It received FDA 510(k) clearance on 2018-07-31 under approval number K181708. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MTS Plazomicin 0.016-256 µg/mL?

MTS Plazomicin 0.016-256 µg/mL is a medical device that received FDA 510(k) clearance on 2018-07-31. It is manufactured by Liofilchem s.r.l.. The 510(k) number is K181708.

When was MTS Plazomicin 0.016-256 µg/mL approved by the FDA?

MTS Plazomicin 0.016-256 µg/mL received FDA 510(k) clearance on 2018-07-31, under approval number K181708.

What company makes MTS Plazomicin 0.016-256 µg/mL?

MTS Plazomicin 0.016-256 µg/mL is manufactured by Liofilchem s.r.l..

What is the FDA product code for MTS Plazomicin 0.016-256 µg/mL?

The FDA product code for MTS Plazomicin 0.016-256 µg/mL is JWY.

Other Devices by Liofilchem s.r.l.

View all 35 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.